<DOC>
	<DOC>NCT02836366</DOC>
	<brief_summary>With this study results of the TargonÂ® PH+ nail, developed for the treatment of humeral head fractures, will be investigated clinically, radiological evaluation is optional. The primary objective of this study is to examine the effect of a plating treatment on the speed of recovery of functional capacity in adult patients. Secondary aims are to examine the level of pain, patient satisfaction, shoulder function, quality of life, radiological evaluation and complications. Targon PH+ is CE certified. The study is a non-interventional cohort study sponsored by Aesculap</brief_summary>
	<brief_title>Targon PH+ Follow-Up</brief_title>
	<detailed_description />
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Shoulder Fractures</mesh_term>
	<criteria>patients with a three or fourfragmentfracture of the proximal humerus, with dislocation on Xray older than 60 years of age written and signed patient consent Fractures more than 14 days old multiple comorbidity multitrauma (Injury Severity Score &gt; 15) prev. surgery on the injured shoulder severely deranged function caused by a previous disease headsplit proximal humerus fracture combined humerus head and shaft fractures pseudarthroses crushed head cap of the humerus head (AO 11 C3 fractures) isolated avulsion fracture of a tuberosity unwillingness or inability to follow protocol instructions and study requirements (followup visits) no signed informed consent treatment not in line with Instructions for Use (IfU)</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Proximal humerus</keyword>
	<keyword>Fracture</keyword>
	<keyword>Nailing</keyword>
</DOC>